Machine-learning aided in situ drug sensitivity screening predicts treatment outcomes in ovarian PDX tumors.
Cotler MJ, Ramadi KB, Hou X, Christodoulopoulos E, Ahn S, Bashyam A, Ding H, Larson M, Oberg AL, Whittaker C, Jonas O, Kaufmann SH, Weroha SJ, Cima MJ.
Cotler MJ, et al. Among authors: oberg al.
Transl Oncol. 2022 Jul;21:101427. doi: 10.1016/j.tranon.2022.101427. Epub 2022 Apr 26.
Transl Oncol. 2022.
PMID: 35472731
Free PMC article.
Long-term treatment outcomes for patients with high grade ovarian cancers have not changed despite innovations in therapies. ...
Long-term treatment outcomes for patients with high grade ovarian cancers have not changed despite innovations in therapies. ...